Institute of Pathology

Macrophages inhibit Coxiella burnetii by the ACOD1-itaconate pathway for containment of Q fever (2022) Kohl L, Siddique MNAA, Bodendorfer B, Berger R, Preikschat A, Daniel C, Ölke M, et al. Journal article Salivary carcinosarcoma: insight into multistep pathogenesis indicates uniform origin as sarcomatoid variant of carcinoma ex pleomorphic adenoma with frequent heterologous elements (2022) Ihrler S, Stiefel D, Jurmeister P, Sandison A, Chaston N, Laco J, Zidar N, et al. Journal article Localization and characterization of proenkephalin-A as a potential biomarker for kidney disease in murine and human kidneys (2022) Fuchs MAA, Schrankl J, Wagner C, Daniel C, Kurtz A, Broeker KAE Journal article Prostate Adenocarcinoma Grade Group 1: Rationale for Retaining a Cancer Label in the 2022 World Health Organization Classification (2022) Netto GJ, Amin MB, Compérat EM, Gill AJ, Hartmann A, Moch H, Menon S, et al. Journal article Proficiency testing of PIK3CA mutations in HR+/HER2-breast cancer on liquid biopsy and tissue (2022) Vollbrecht C, Hoffmann I, Lehmann A, Merkelbach-Bruse S, Fassunke J, Wagener-Ryczek S, Ball M, et al. Journal article Spatial Immunephenotypes of Distant Metastases but not Matched Primary Urothelial Carcinomas Predict Response to Immune Checkpoint Inhibition (2022) Erlmeier F, Klümper N, Landgraf L, Strissel P, Strick R, Sikic D, Taubert H, et al. Journal article Cervical intraepithelial neoplasia grade 3: development during pregnancy and postpartum (2022) Stübs F, Mergel F, Koch M, Dietl A, Schulmeyer C, Adler W, Geppert CI, et al. Journal article Growth Arrest-Specific 6 in Chromophobe Renal Cell Carcinoma (2022) Mikuteit M, Zschäbitz S, Erlmeier M, Autenrieth M, Weichert W, Hartmann A, Steffens S, Erlmeier F Journal article Targeting the innate repair receptor axis via erythropoietin or pyroglutamate helix B surface peptide attenuates hemolytic-uremic syndrome in mice (2022) Dennhardt S, Pirschel W, Wissuwa B, Imhof D, Daniel C, Kielstein JT, Hennig-Pauka I, et al. Journal article Intralesional TLR4 agonist treatment strengthens the organ defense against colonizing cancer cells in the brain (2022) Blazquez R, Chuang HN, Wenske B, Trigueros L, Wlochowitz D, Liguori R, Ferrazzi F, et al. Journal article